Back to Search
Start Over
Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents infected with HIV: The PositHIVe Health Study
- Source :
- PLoS ONE, PLoS ONE, Vol 13, Iss 1, p e0190785 (2018)
- Publication Year :
- 2017
-
Abstract
- HIV-infected children and adolescents may be at risk for cardiovascular disease due to chronic inflammation and exacerbation of risk factors. The aim of this study was as follows: 1) compare cardiovascular risk factors, chronic inflammation, and carotid intima-media thickness (IMTc) between the HIV and control groups; 2) determine the association of HIV and antiretroviral (ART) regimens with cardiovascular risk factors, chronic inflammation, and IMTc; and 3) identify variables associated with elevated IMTc. Cross-sectional analysis of 130 children and adolescents, 8-15 years of age, divided into HIV-infected (n = 65) and healthy control (n = 65) participants. Body fat, blood pressure, glycemia, insulin, and glycated hemoglobin, total cholesterol and fractions (LDL-C and HDL-C), triglycerides, C-reactive protein (CRP), interleukin (IL)-6, tumor necrosis factor-alpha (TNF-α), and the IMTc were measured. The results showed HIV-infected children and adolescents had higher levels of glycemia (87.9 vs. 75.9 mg.dL-1, p< 0.001), LDL-c (94.7 vs. 79.5 mg.dL-1, p = 0.010), triglycerides (101.2 vs. 61.6 mg.dL-1, p< 0.001), CRP (1.6 vs. 1.0 mg.L-1, p = 0.007), IL-6 (1.42 vs. 0.01 pg.mL-1, p< 0.001), TNF-α (0.49 vs. 0.01 pg.mL-1, p< 0.001), mean IMTc (0.526 vs. 0.499 mm, p = 0.009), and lower HDL-c (53.7 vs. 69.4 mg.dL-1, p< 0.001) compared to controls. Systolic blood pressure (β = 0.006, p = 0.004) and TNF-α (β = -0.033, p = 0.029) accounted for 16% of IMTc variability in HIV-infected children and adolescents. In patients using protease inhibitors-based ART, male gender (β = -0.186, p = 0.008), trunk body fat (β = -0.011, p = 0.006), glucose (β = 0.005, p = 0.046), and IL-6 (β = 0.017, p = 0.039) accounted for 28% of IMTc variability. HIV-infected children and adolescents may be at risk for premature atherosclerosis due to chronic inflammation and dyslipidemia. Interventions with the potential to improve lipid profile, mitigate inflammation, and reduce cardiovascular risk are needed.
- Subjects :
- Blood Glucose
Male
RNA viruses
Exacerbation
Physiology
medicine.medical_treatment
lcsh:Medicine
HIV Infections
030204 cardiovascular system & hematology
Adolescents
Pathology and Laboratory Medicine
Gastroenterology
Carotid Intima-Media Thickness
Biochemistry
chemistry.chemical_compound
Families
0302 clinical medicine
Immunodeficiency Viruses
Risk Factors
Immune Physiology
Medicine and Health Sciences
Public and Occupational Health
030212 general & internal medicine
lcsh:Science
Child
Children
Immune Response
Adiposity
Innate Immune System
Multidisciplinary
medicine.diagnostic_test
Lipids
Vaccination and Immunization
Cholesterol
Anti-Retroviral Agents
Adipose Tissue
Medical Microbiology
Viral Pathogens
Viruses
Cytokines
Infectious diseases
Female
medicine.symptom
Pathogens
Anatomy
Research Article
medicine.medical_specialty
Adolescent
Immunology
Antiretroviral Therapy
Inflammation
Viral diseases
Microbiology
03 medical and health sciences
Sex Factors
Signs and Symptoms
Antiviral Therapy
Diagnostic Medicine
Internal medicine
Retroviruses
medicine
Humans
Protease Inhibitors
Microbial Pathogens
Dyslipidemias
business.industry
Interleukin-6
Insulin
lcsh:R
Lentivirus
Organisms
Biology and Life Sciences
HIV
Molecular Development
medicine.disease
Atherosclerosis
Blood pressure
Cross-Sectional Studies
Biological Tissue
chemistry
Age Groups
Immune System
People and Places
lcsh:Q
Population Groupings
Glycated hemoglobin
Preventive Medicine
Lipid profile
business
Dyslipidemia
Biomarkers
Developmental Biology
Subjects
Details
- ISSN :
- 19326203
- Volume :
- 13
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- PloS one
- Accession number :
- edsair.doi.dedup.....7b005139a11d7d27c5e41d7f0ac9f368